Change search
ReferencesLink to record
Permanent link

Direct link
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Show others and affiliations
2005 (English)In: Hypertension, ISSN 1524-4563, Vol. 45, no 1, 46-52 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 45, no 1, 46-52 p.
Keyword [en]
Aged, Aged; 80 and over, Angiotensin II Type 1 Receptor Blockers/*therapeutic use, Antihypertensive Agents/*therapeutic use, Atenolol/*therapeutic use, Atrial Fibrillation/complications, Comorbidity, Diabetes Complications, Double-Blind Method, Female, Humans, Hypercholesterolemia/complications, Hypertension/*complications/drug therapy, Hypertrophy; Left Ventricular/*complications, Incidence, Losartan/*therapeutic use, Male, Middle Aged, Severity of Illness Index, Stroke/epidemiology/*prevention & control, Treatment Outcome
URN: urn:nbn:se:umu:diva-6266DOI: doi:10.1161/01.HYP.0000151324.05355.1cPubMedID: 15583076OAI: diva2:145935
Available from: 2007-12-08 Created: 2007-12-08 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lindholm, Lars H
By organisation
Family Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 26 hits
ReferencesLink to record
Permanent link

Direct link